Karen Kage

Research Associate at Altor Bioscience Corporation

Karen Kage's Professional Contact Details

Email (Verified)

****@altorbioscience.com

Get Email Address

(954) 443-8600

Location

Fort Lauderdale, Florida, US

Company

Altor Bioscience Corporation

Person Seniority

entry

Location Postal Code

33316

Karen Kage's Current Company Details

Altor Bioscience Corporation

Miramar, Florida, US • 52 Employees

biotechnology

Altor currently is developing products based its three Technology Platforms including: 1) STAR Technology (single chain TCR targeting intracellular antigens, such as p53) 2) Tissue Factor Antagonists 3) IL-15 Technology Partnering opportunities include: 1) ALT-801 (p53 scTCR/IL-2 fusion) has completed phase II for melanoma and bladder cancer 2) ALT-836 (anti-tissue factor mAb) has completed phase II for ALI/ARDS and phase I for solid tumors 3) ALT-803 (IL-15 superagonist complex) is in clinical trials for various solid/hematological cancers. 4) ALT-802 (p53 scTCR/IgG1 fusion) in preclinical for cancer For more detailed descriptions, please go to www.altorbioscience.com

Founded Year

2002

Organization Website

altorbioscience.com

Organization Languages

English

Organization Revenue

3000

Current Technologies

google analytics

bootstrap framework

nginx